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Human cytomegalovirus (HCMV), strain AD169, contains four genes (US27, US28, UL33, and UL78) that encode putative
homologues of cellular G protein-coupled receptors (GCRs). GCRs transduce extracellular signals to alter intracellular
processes, and there is evidence that HCMV may elicit such changes at early times following infection. The US27, US28,
and UL33 genes are transcribed during infection, and the US28 gene product has been found to be a functional receptor
for the b-chemokine class of immune modulators. The US27, UL33, and UL78 gene products have not been described and
we have concentrated on identifying the UL33 protein because it is the most highly conserved of the GCR homologues
among the human b and g herpesviruses. We report here cloning UL33 into a recombinant baculovirus (rBV) and expressing
it in insect cells; constructing a mutant HCMV with a disrupted UL33 gene; and identifying the UL33 protein in HCMV-
infected cells and virus particles. Our results demonstrate that the UL33 protein (i) is expressed as a 36-kDa, heat-
aggregatable protein in rBV-infected cells, (ii) is modified heterogeneously by asparagine-linked glycosylation and expressed
as a ⁄58-kDa glycoprotein that is present in the region of the cytoplasmic inclusions in HCMV-infected fibroblasts, (iii) is
present in virions and two other enveloped virus particles, and (iv) is not essential for growth of HCMV in human foreskin
fibroblast cultures. q 1996 Academic Press, Inc.
INTRODUCTION loop, thought to be necessary for the receptor – G protein
interaction (Oliveira et al., 1993), and other conserved
Human cytomegalovirus (HCMV) is a member of the
residues throughout are commonly found (Fraser et al.,
herpesvirus family (human herpesvirus 5) and is a ubiqui-
1994; Horuk, 1994).
tous pathogen that causes many disorders in immunode-
GCRs are typically the first members involved in aficient or immunocompromised individuals and in neo-
signal transduction cascade initiated by ligand binding
nates (Alford and Britt, 1990; Bruggeman, 1993). Analysis
and receptor activation; these ligands can be biogenic
of the nucleotide sequence of the 230-kb genome of
amines, peptides, odorants, tastants, or other signals
HCMV strain AD169 (Chee et al., 1990a) revealed four
(Fraser et al., 1994). Ligand binding is predicted to alter
open reading frames (ORFs), UL33, UL78, US27, and
the conformation of a GCR, generating an active form
US28, that potentially encode homologues of cellular G of the receptor, and dissociation of the ligand returns
protein-coupled receptors (GCRs) (Attwood and Findlay, the GCR to an inactive state (Fraser et al., 1994). There
1994; Chee et al., 1990b), a family of signal transducing are also examples of constitutively activated, mutant
proteins found in numerous biological systems (Attwood GCRs that are apparently fixed in an active conforma-
and Findlay, 1994; Kolakowski, 1994). tion; these do not require ligand binding for activation
GCRs characteristically have seven membrane-span- (Shenker, 1994).
ning domains and generally contain two disulfide-linked An activated GCR transmits its signal to a coupled
cysteines in the second and third extracytoplasmic loops heterotrimeric G protein, which itself becomes activated
(Fraser et al., 1994); multiple serines and threonines (Fra- and, in turn, alters the activity of target proteins; for exam-
ser et al., 1994) and a palmitoylated cysteine (Papac et ple, upregulating phosphatidylinositol phospholipase C
al., 1992) in the intracellular, carboxyl tail; and aspara- (Sleight and Lieberman, 1995), modulating adenylate cy-
gine-linked glycosylation on extracellular domains (Fra- clase (Sleight and Lieberman, 1995), or gating ion chan-
ser et al., 1994). In addition, an N-P-X-X-Y motif in the nels (Sleight and Lieberman, 1995; Yatani, 1995) are com-
seventh transmembrane domain (Berlose et al., 1994), a mon effects. These affected proteins amplify and propa-
conserved D-R-Y sequence in the second intracellular gate the signal by altering the levels of small intracellular
second messenger molecules, such as inositol trisphos-
phate, diacylglycerol, arachidonic acid, cyclic AMP1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (410)-955-3023. E-mail: Wade_Gibson@qmail.bs.jhu.edu. (cAMP), cyclic GMP, calcium, potassium, or sodium
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(Sleight and Lieberman, 1995). Examples of signal trans- (NIEPs), and dense bodies (DBs) were effectively puri-
fied, separated from one another, and concentrated bymission by second messengers include (i) liberating free
calcium, to coordinate with calcium-binding proteins and banding three times in potassium tartrate gradients as
documented previously (Irmiere and Gibson, 1983; Talbotincrease calcium-dependent processes (Dedman and
Kaetzel, 1995), (ii) interacting with protein kinase C (PKC), and Almeida, 1977), except that the virus pellets were
stored at 0807 without solubilization. Spodoptera frugi-to activate other proteins (Sleight and Lieberman, 1995),
and (iii) interacting with cAMP-dependent proteins, to perda (Sf9) cells (ATCC CRL-1711) were grown and in-
fected with baculovirus Autographa californica nuclearregulate transcription or other intracellular processes
(Lalli et al., 1993; Sleight and Lieberman, 1995). polyhedrosis virus (AcNPV) as described (Gruenwald and
Heitz, 1993; O’Reilly et al., 1992). The recombinant bacu-Changes in some second messengers have been
noted during HCMV infection of human fibroblasts. In- loviruses (rBVs) rBV-33, rBV-Tag33, and rBV-N33 were
prepared using the baculovirus transfer plasmids de-creases of inositol trisphosphate, diacylglycerol, arachi-
donic acid, cAMP, calcium, and sodium, as well as in- scribed below and plaque purified at least twice (Gruen-
wald and Heitz, 1993; O’Reilly et al., 1992).creases of the transcription factors c-jun, c-myc, and c-
fos, have all been detected early in infection (Albrecht et
al., 1991), leading to the hypothesis that one or more of Construction of rBV transfer plasmids
the virally encoded GCRs is responsible for these
changes. Supporting such a relationship are data show- The HCMV ORF UL33 (Chee et al., 1990a,b) was cloned
through the polymerase chain reaction (PCR) (Scharf,ing that the HCMV US28 ORF encodes a functional b-
chemokine receptor that facilitates an increase of intra- 1990) by using a plasmid containing the HindIII J frag-
ment of HCMV, strain AD169 (gift of Marc Chee, Medicalcellular calcium upon stimulation (Gao and Murphy,
1994; Neote et al., 1993). The other HCMV GCRs encoded Research Council), as a template and synthetic primers,
with BamHI ends, which consisted of nucleotides 43246 –by US27 and UL33 are also most homologous to chemo-
kine receptors (Horuk, 1994; this report), proteins in- 43269 for the coding strand and 44429– 44453 for the
complementary strand of the AD169 genome (Chee etvolved in chemotaxis of monocytes and granulocytes
(Ahuja et al., 1994; Durum and Oppenheim, 1993). Since al., 1990a). The plasmid BJM1 was made by inserting the
resulting 1.2-kb UL33 PCR product into the BamHI siteHCMV can be found in these cell types in vivo (Brugge-
man, 1993; von Laer et al., 1995), it is possible that HCMV of the vector pcDNA1 (Invitrogen, San Diego, CA). Subse-
quent dideoxy sequencing of the PCR-generated insertuses its own GCR homologues to take advantage of sig-
nal transduction pathways normally used by the host (Sequenase, United States Biochemical, Cleveland, OH)
(Kraft et al., 1988) revealed one point mutation (baseimmune system. Because of the potential involvement of
these GCRs in the pathology of HCMV infection, it is number 840 of the UL33 coding sequence, C for T), prob-
ably introduced by PCR (Smith et al., 1993), that was notimportant to determine their function and mechanism of
action. repaired because it did not change the codon specificity
for asparagine.We (Welch et al., 1991) and others (Davis-Poynter et
al., 1995; Jones et al., 1995) have previously shown that A second plasmid, pTag33, that contained the ORF for
an epitope-tagged version of the UL33 protein was made.the three ORFs, UL33, US27, and US28, are transcribed
maximally in HCMV-infected fibroblasts at late times after The UL33 ORF from BJM1 was first cloned into the BamHI
site of the vector pET-11c (Novagen, Madison, WI), creat-infection. In this report we have used Western immunoas-
says and indirect immunofluorescence to identify and to ing pET-33. BJM1 was then cut with HindIII, the 5* over-
hang filled with the large fragment of DNA polymerase Ibegin to characterize the protein product of the HCMV
strain AD169 UL33 ORF. (Klenow fragment, New England Biolabs, Beverly, MA),
and cut with PvuI. The 5* coding region of the UL33 ORF(Initial reports of this work were presented at the 17th
International Herpesvirus Workshop in Edinburgh, Scot- from pET-33 (containing the coding sequence for an 11-
amino-acid addition) was cut with NdeI, treated as aboveland, August 1– 7, 1992, and at the 20th International
Herpesvirus Workshop in Groningen, the Netherlands, with a Klenow fragment, and subsequently cut with PvuI.
The blunt-to-PvuI fragment from pET-33 was subclonedJuly 30– August 3, 1995.)
in place of the excised region of the UL33 ORF in BJM1,
preserving the HindIII site. The plasmid pK-Tag33 wasMATERIALS AND METHODS
created by inserting a complementary pair of oligonucle-
Cells and viruses
otides containing a Kozak-consensus ATG start codon
in place of the existing ATG initiating codon in pTag33The propagation of human foreskin fibroblasts (HFF
cells) and MRC5 cells and their infection with HCMV (Kaufman, 1990): pTag33 was partially digested with NheI
(Parker et al., 1977) and then cut with HindIII. The double-strain AD169 (ATCC VR-538) have been described before
(Gibson, 1981b; Kaye et al., 1992; Weiner and Gibson, stranded oligonucleotide, containing ends compatible
with these same restriction sites and an internal BglII1983). HCMV virions, noninfectious enveloped particles
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site 5* to the ATG, was then cloned into the prepared UL16 HCMV insertion mutants (Browne et al., 1992; Kaye
et al., 1992). The correct insertion of lacZ sequencespTag33 vector.
pVL-33, the transfer plasmid for rBV-33, was con- within the UL33 gene and the absence of contaminating
wild-type virus were established by Southern hybridiza-structed by cloning the UL33 ORF from BJM1 into the
BamHI site of the baculovirus transfer vector pVL1393 tion (Sambrook et al., 1989). HCMV plaque assays were
done as described elsewhere (Browne et al., 1992).(Pharmingen, San Diego, CA). pVL-Tag33, the transfer
plasmid for rBV-Tag33, was constructed by inserting the
Preparation of UL33 antiserum and F(ab)2 fragments1.3-kb BglII– EcoRI extended UL33 ORF from pK-Tag33
into the corresponding sites of the baculovirus transfer Approximately 2 mg of a synthetic peptide correspond-
ing to the predicted 17 carboxy-terminal amino acids ofvector pVL1392 (Pharmingen). pVL-N33 is the rBV trans-
fer plasmid for rBV-N33 and codes for a different amino- the protein encoded by UL33 (UL33 peptide, NH2-TKI-
PHRLSQSHHNLSGV-CO2H) was coupled to 2 mg of key-terminally extended version of the UL33 protein; it was
constructed as follows. First, an amino-terminal exten- hole limpet hemocyanin (KLH; Pierce, Rockford, IL) via
an EDC (1-ethyl-3-(dimethylaminopropyl) carbodiimide)sion of UL33 was generated by PCR; the template was
the HCMV HindIII J fragment, cleaved with BfaI; the cod- bridge, according to the manufacturer (Imject kit; Pierce);
this immunogen was named KLH-UL33. Also, 4 mg ofing strand primer included a BamHI site followed by the
first 21 codons predicted in the longer, spliced mRNA for UL33 peptide was crosslinked to itself with 0.1% glutaral-
dehyde, essentially as described (Collawn and Paterson,UL33 (Davis-Poynter et al., 1995); the other primer for the
complementary strand was an internal 20-mer previously 1995), to create UL33-UL33. One female New Zealand
white rabbit (Hazleton Research Products, Inc., Denver,used for sequencing. The final PCR product was cut with
BamHI and DraIII and used to replace the BglII– DraIII PA) was immunized with a primary injection of 100 mg
of KLH-UL33 in Freund’s complete adjuvant, followed byfragment in pVL-Tag33.
Cloning and plasmid construction and purification was two similar boosts in Freund’s incomplete adjuvant (IFA)
(Harlow and Lane, 1988). Subsequent boosts consisteddone by standard techniques with strains MC1061/P3
(Invitrogen) and XL1-Blue (Stratagene, La Jolla, CA) of of 40 mg of UL33-UL33 in IFA. Serum was collected from
the immunized animal periodically after at least six UL33-Escherichia coli (Sambrook et al., 1989; Scharf, 1990).
The composition and orientation of each construct was UL33 booster injections and stored at 0807 until use;
this antiserum was called rabbit anti-33.verified by restriction analyses and dideoxy sequencing
(Kraft et al., 1988) when necessary. F(ab)2 fragments were prepared as follows. The IgG
fraction of the rabbit anti-33 antiserum was isolated by
binding to a Fast-Flow Protein G Sepharose column (Phar-Construction of UL33-disrupted HCMV
macia, Piscataway, NJ) in 20 mM sodium phosphate
buffer (pH 7.3), washing with 1 M NaCl in 20 mM sodiumA mutant of HCMV that contains a disrupted UL33 ORF
and is called HCMV D33 (D33) was made as follows. phosphate buffer (pH 7.3), and eluting the IgG with 50
mM glycine– HCl (pH 3.0) in 5-ml fractions into tubesA fragment of the AD169 genome (nucleotides 38517 –
46434) containing the UL33 coding region was cloned containing 500 ml of 1 M Tris – HCl (pH 7.5) (Harlow and
Lane, 1988). Fractions containing IgG were identified byin pUC13 to give pHBHJ. This plasmid was digested with
AsuII which cleaves it once, 23 bp 3* of the ATG of sodium dodecyl sulfate – polyacrylamide gel electropho-
resis (SDS– PAGE) and staining with Coomassie brilliantthe UL33 ORF. A linker, constructed by annealing the
oligonucleotides 5*-CGAAAGATCTAGGCCTTT-3* and 5*- blue (CBB), and the amount of protein present in each
was measured by the BCA protein assay (Pierce). IgG-CGAAAGGCCTAGAT-3* was ligated into AsuII-cleaved
and phosphatased pHBHJ to give pAsuII. The BglII site containing fractions were pooled, dialyzed overnight
against 200 mM sodium acetate (pH 4.0), and treatedpresent in the linker is unique in pAsuII, and a 3.8-kb
BamHI fragment containing E. coli lacZ sequences down- with 100 mg pepsin (Boehringer-Mannheim, Indianapolis,
IN)/mg IgG for 4 hr at 377 (Harlow and Lane, 1988; Hil-stream of the CMV major immediate-early promoter de-
rived from the plasmid pMV1 (Browne et al., 1992) was dreth and Hyman, 1989). The preparation was neutralized
with 0.05 vol of 1 M Tris – HCl (pH 7.5) and dialyzed over-ligated into BglII-cut and phosphatased pAsuII to give
pUL33DgalE. This plasmid contains the lacZ gene in the night against calcium- and magnesium-free PBS (CMF-
PBS). Fc fragments and incompletely cleaved IgG mole-opposite transcription polarity to that of UL33. pUL33D-
galE (2.5 mg) was linearized with BamHI and cotrans- cules were removed from the F(ab)2 preparation by their
binding to protein A– Sepharose beads (Sigma, St. Louis,fected with 20 mg of AD169-infected cell DNA into sub-
confluent monolayers of MRC5 cells by a modified cal- MO) in CMF-PBS. The remaining, unbound F(ab)2 frag-
ments, called rabbit F(ab)2 Anti-33, were concentratedcium phosphate precipitation method (Chen and
Okayama, 1987). Resulting recombinant viruses were (Centricon 30; Amicon, Beverly, MA) and determined to
be free of Fc fragments and IgG by SDS– PAGE and CBBidentified by their blue-plaque phenotype, isolated, and
plaque-purified as previously described for the UL18 and staining.
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SDS –PAGE, peptide comparisons, and Western 8 days after infection with HCMV or 3 days after infection
with rBVs.immunoassays
Cells were fixed with 3% paraformaldehyde (Poly-
SDS – PAGE was done essentially as described pre- sciences, Inc., Warrington, PA) in CMF-PBS and perme-
viously (Gibson, 1981b). Exceptions were using 10 mM abilized with 0.5% Triton X-100 in TNgly (10 mM Tris –
dithiothreitol (DTT) instead of 10% b-mercaptoethanol in HCl (pH 7.4), 0.9% NaCl, and 10 mM glycine) (Machamer
sample solubilizing buffer (Parker et al., 1993) and heat- and Rose, 1988; Rose and Bergmann, 1982). All subse-
ing samples in a 427 water bath (instead of 1007) for 3 quent incubations were 35 min long at 257 and were
min (Parker et al., 1993), unless stated otherwise in the followed by three washes with TNgly (Harlow and Lane,
text. Protein separations were in 12% polyacrylamide 1988). Slides were incubated with one of the following
gels, and peptide-separating, second-dimension gels primary reagents, diluted in Western blocking buffer: non-
were 18% polyacrylamide, crosslinked with diallyltartardi- specific rabbit serum (1:40), nonspecific rabbit F(ab)2 (50amide (DATD; Bio-Rad, Melville, NY) (Anker, 1970; Gib-
mg/ml), nonspecific rabbit Fc (25 mg/ml), rabbit anti-33
son, 1981b). Peptide comparisons were done by two- antiserum (1:40), rabbit F(ab)2 anti-33 (50 mg/ml), ordimensional SDS– PAGE followed by Western immuno- mouse anti-Tag (1:100). Peptide competition experiments
assay, as previously described (Schenk et al., 1991). Pro- were done by adding a 1000-fold molar excess of either
teins were cleaved at tryptophan residues, after excising UL33 peptide or C1 peptide (Schenk et al., 1991) to di-
the lanes containing samples, by treatment in situ with luted rabbit F(ab)2 anti-33, rocking the solution for 30N-chlorosuccinimide (NCS; Aldrich, Milwaukee, WI) min at 257, and subjecting the solution to centrifugation
(Lischwe and Ochs, 1982; Schenk et al., 1991). Immobi- (8000 g, 257, 1 min) to pellet insoluble material, all prior
lon-P membranes were stained for the presence of pro- to use in the assay (Jemmerson and Hutchinson, 1990).
tein with 0.1% CBB in 50% acetic acid and 10% methanol, The primary reagents were detected as specified, by
as indicated. incubation with goat IgG anti-rabbit (GAR)-lissamine rho-
Western immunoassays were done essentially as de- damine sulfonyl chloride (LRSC) (1:125), goat IgG anti-
scribed by Towbin et al. (1979), using rabbit anti-33 (1:40), mouse (GAM)-fluorescein isothiocyanate (FITC) (1:50),
rabbit anti-minor capsid protein (anti-miCP, 1:50) (Gibson goat F(ab)2 anti-rabbit F(ab)2 (GFARF)-LRSC (1:125), oret al., 1996), or mouse monoclonal anti-lower matrix pro- goat F(ab)2 anti-rabbit Fc (GFARFc)-FITC (1:50). Each sec-tein (Anti-LM, 1:100; DuPont No. 9220), prepared in 5% ondary reagent reacted species- or antibody-fragment-
BSA, 0.9% NaCl, 0.02% NaN3, and 10 mM Tris – HCl (pH specifically, and neither fluorochrome exhibited signifi-
7.4) (Western blocking buffer), and detected with 125I- cant cross-excitation. All nonspecific sera, nonspecific
labeled protein A (Amersham, Arlington Heights, IL) IgG subfragments, and secondary reagent conjugates
(Welch et al., 1993). Specific electrotransfer conditions were purchased from Jackson ImmunoResearch. Cov-
were: Immobilon-P membrane (Millipore, Bedford, MA); erslips were attached to the processed slides with a drop
20% methanol, 50 mM Tris buffer; and transfer time calcu- of Mowiol mounting medium, containing Mowiol 4-88
lated from the equation: transfer time equals gel length (Calbiochem, San Diego, CA No. 475904) and the anti-1 width 1 2.5 mA per 0.5 hr (Welch et al., 1993). The fade agent DABCO (Sigma), prepared as described (Har-
mouse monoclonal antibody, anti-Tag (recognizes the T7- low and Lane, 1988), and cells were examined and photo-
Tag epitope on the amino terminus of the UL33 protein graphed with an Olympus BH-2 microscope, equipped
coded in the construct pET-33; Novagen), was diluted with a 40X SPlan objective lens, using Kodak Ektachrome
1:10,000 in Western blocking buffer and detected with 400 ASA color slide film
rabbit anti-mouse IgG (10 mg/ml, Jackson ImmunoRe-
search, West Grove, PA), followed by 125I-labeled protein
Preparation of cells and membranes and treatmentA. Fluorograms were prepared from the processed Im-
with peptide N-glycosidase Fmobilon-P sheets by using XAR-5 film (Eastman-Kodak,
Rochester, NY) and a calcium-tungstate intensifying HCMV-infected, HCMV D33-infected, or noninfected
screen at 0807 (Laskey and Mills, 1977). HFF cells were recovered from 32-oz glass bottles (5
1 107 cells/bottle) (Gibson, 1981b) 8 days after infection,Indirect immunofluorescence
resuspended in CMF-PBS (1 ml/bottle), and frozen at
0807. rBV-infected cells were prepared similarly (6 1Each chamber of an Erie SuperCell 8 chamber slide
(VWR No. 48393-406) was seeded with 6.25 1 104 HFF 106 cells/1 ml of CMF-PBS) and frozen at 0807. Cellular
membranes were prepared from fresh or frozen cellscells or Sf9 cells. HFF cells were infected the next day
with wild-type or D33 HCMV or left uninfected; Sf9 cells (Sung et al., 1991) that had been disrupted by forcing
through a 27-gauge needle (Parker et al., 1993).were infected with rBVs 20 min after seeding. Virus
stocks were clarified by centrifugation at 8000 g for 1 For peptide N-glycosidase F (PNGase F) treatment,
membrane preparations (20 mg of protein) were first incu-min in a microfuge to pellet cellular debris before inocu-
lating cultures. Immunofluorescence assays were done bated with 1/5 vol of freshly prepared 60 mM DTT, 12%
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SDS, and 300 mM Tris – HCl (pH 7.0) (i.e., 61 solubilizing
buffer without glycerol or bromophenol blue) at 427 for 5
min. Pelleted virus particles were solubilized in 60 ml of
fresh 21 solubilizing buffer, diluted 1:1 with water, and
warmed as above. Solubilized membranes and virus par-
ticles were combined with 1/5 vol of 61 PNGase ‘‘B’’
buffer, consisting of 90 mM EDTA, 20% Nonidet P-40 (NP-
40), 24 mM o-phenanthriline, 6 mM PMSF, and 450 mM
glycine– HCl (pH 9.3), and incubated with or without 200
mU PNGase F (Boehringer-Mannheim No. 1365-169)
overnight at 377 (Haltiwanger and Hart, 1993; Sung et al.,
1991; Tarentino and Plummer, 1994). Treated samples
were then prepared for SDS – PAGE and Western immu-
noassay by adding 1/3 vol of 41 solubilizing buffer.
RESULTS
Expression of the UL33 protein from recombinant
baculoviruses
We began this work by first attempting to clone and
identify the UL33 protein in a high-expression system. FIG. 1. Expression of recombinant pUL33. Western immunoassay
shows proteins produced by Sf9 cells that were infected with wild-typeWe used the recombinant baculovirus system (O’Reilly
baculovirus (BV; lanes 1, 4, 7, and 10), rBV-33 (lanes 2, 5, 8, and 11),et al., 1992) because of its ability to carry out many post-
or rBV-Tag33 (lanes 3, 6, 9, and 12) and harvested 3 days after infection.translational protein modifications and because it has
Whole cell lysates were prepared in solubilizing buffer and not heated
been used successfully to express other cloned GCRs (lanes 1 –3, 7 –9) or heated in a boiling water bath (lanes 4 –6, 10 – 12)
(Mouillac et al., 1992; Parker et al., 1993; Zastawny et al., prior to SDS –PAGE. Western immunoassays were done with the anti-
33 antiserum or anti-Tag antibody, as indicated. Circles are shown next1994). We used the rabbit anti-33 anti-peptide antiserum
to the Tag33 protein, detected by both anti-33 and anti-Tag. Arrowto detect the protein by Western immunoassay and im-
indicates GCR multimers. Molecular weight (in kDa) was estimatedmunofluorescence. We made and compared two rBVs, from molecular weight markers included during SDS – PAGE (Mark 12;
one expressing the UL33 ORF (rBV-33, producing recom- Novex, San Diego, CA) that were visualized by staining that portion
binant UL33 protein, pUL33) and one expressing pUL33 of the Immobilon-P with Coomassie brilliant blue (CBB) immediately
following electrotransfer.with an 11-amino-acid epitope (T7 gene 10 sequence,
detectable with a commercial mouse monoclonal anti-
body, anti-Tag) (Lutz-Freyermuth et al., 1990; Tsai et al.,
Fig. 1, lane 9) or heat-aggregated (Fig. 1, lane 12), reactedKeene, 1992) fused to its amino end (rBV-Tag33, produc-
with the anti-Tag antibody, confirming its identity as theing pTag33). Construction and use of these reagents is
recombinant pTag33. The higher-molecular-weight im-described under Materials and Methods.
munoreactive material (e.g., see arrow, Fig. 1) is mostSf9 cells were infected with the recombinant baculovi-
likely multimers of pUL33 and pTag33 that did not disso-ruses rBV-33 or rBV-Tag33, harvested in 21 SDS – PAGE
ciate during SDS – PAGE (Sung et al., 1991). No similarsample buffer 3 days later, and analyzed by SDS – PAGE
protein was detected in wild-type BV-infected Sf9 cellsand Western immunoassays (Fig. 1). Two sets of samples
(BV; lanes 1, 4, 7, 10). The presence of this protein onlywere analyzed in parallel; one was probed with rabbit
in rBV-33-infected cells, its reaction with the anti-33 anti-anti-33 (Fig. 1, lanes 1 – 6) and the other with mouse anti-
serum, and its size difference and reaction with the anti-Tag (Fig. 1, lanes 7 – 12). rBV-33 expressed a 36-kDa
Tag antibody when fused with the 11-amino-acid epitopeprotein (Fig. 1, lane 2), reactive with the anti-33 antiserum.
establish its identity as pUL33.rBV-Tag33 also expressed a protein that was immunore-
active with the anti-33 antiserum, but its size was slightly
pUL33 expression from a recombinant baculovirus
larger (i.e., 39 kDa, circle in Fig. 1, lane 3) due to the
11-amino-acid epitope added to its amino end. When To investigate the localization of the recombinant UL33
protein, the previously characterized anti-33 antiserumheated in a boiling water bath, as usual prior to SDS –
PAGE (Fig. 1, lanes 4– 6 and 10– 12), both pUL33 and and anti-Tag antibody (Fig. 1) were used in immunofluo-
rescence assays of rBV-infected insect cells. Sf9 cellspTag33 formed high-molecular-weight aggregates that
barely entered the resolving gel (e.g., Fig. 1, lanes 5 and were infected with either wild-type baculovirus (BV), rBV-
33, or rBV-Tag33 and 3 days later were subjected to6), a phenomenon observed with other GCRs and highly
hydrophobic proteins analyzed by SDS – PAGE (Semenza immunofluorescence assays with the anti-33 antiserum
or anti-Tag antibody (Fig. 2). rBV-33-infected cellset al., 1990). Only pTag33, whether monomeric (circle,
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FIG. 2. Recombinant pUL33 expression in rBV-infected Sf9 cells shown by indirect immunofluorescence. Bound primary antibodies, anti-33 or
anti-Tag, were detected by indirect immunofluorescence after incubation with either GAR-LRSC (for rabbit anti-33) or GAM-FITC (for mouse anti-
Tag) as secondary reagents. See text for abbreviations. (A) rBV-33-infected cells assayed with rabbit anti-33, as primary, and GAR-LRSC, as
secondary, antibodies. (B) BV-infected cells assayed with rabbit anti-33, as primary, and GAR-LRSC, as secondary, antibodies. (C and D) rBV-Tag33-
infected cells assayed with both rabbit anti-33 and mouse anti-Tag, as primary reagents and with both GAR-LRSC and GAM-FITC, as secondary
reagents. (E) rBV-infected cells assayed with anti-Tag antibody, as primary reagent, and GAM-FITC, as secondary antibody. LRSC fluorescence is
shown in A –C, FITC fluorescence in D and E.
FIG. 3. GCR33 localizes to the region of the HCMV-infected cell cytoplasmic inclusion. HFFs were infected with wild-type (strain AD169) HCMV
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showed a pattern of generalized extranuclear fluores- (Fig. 3K). Nonspecific Fc binding is also shown in D33-
infected cells (Fig. 3L), demonstrating that although therecence (Fig. 2A) that was absent from BV-infected cells
assayed with the rabbit anti-33 antiserum (Fig. 2B). rBV- is no GCR33 in these cells, D33 still produces an Fc-
binding component in the CIs during infection. This lastTag33-infected cells show the same pattern of fluores-
cence with both anti-33 and anti-Tag antibodies (Figs. control also shows that if Fc were present and the cause
of reactivity in Figs. 3A and 3E, it would have been de-2C and 2D, respectively). The anti-Tag antibody also did
not react with BV-infected cells (Fig. 2E). The unequivocal tected with the anti-Fc-FITC reagent in Fig. 3F.
The specificity of the interaction seen in Fig. 3A wasidentification of pTag33 by its unique epitope, and its
coincident distribution, when visualized with the anti-33 also established by peptide competition experiments. An
unrelated 21-amino-acid peptide, C1 (Schenk et al.,or anti-Tag antibodies, establish both the specificity of
the anti-33 antiserum for pUL33 and the nonnuclear lo- 1991), was unable to compete rabbit anti-33 F(ab)2 bind-
ing at a 1,000-fold molar excess (Fig. 3M), but the 17-calization of pUL33.
amino-acid UL33 peptide at the same concentration com-
pletely blocked the interaction (Fig. 3N). Together, theseGCR33 localizes to cytoplasmic inclusion structures
results show that the rabbit F(ab)2 anti-33 preparationin HCMV-infected cells
specifically reacts with GCR33 in immunofluorescence
Having verified the specificity of the anti-33 antiserum experiments, that GCR33 localizes to the CI region of
and determined some properties of pUL33 expressed in HCMV-infected cells, and that GCR33 is not responsible
rBVs, we next attempted to identify the UL33 protein in for the Fc binding that defines the region of the infected-
HCMV-infected fibroblasts. The UL33 protein expressed cell CIs.
in HCMV-infected cells was called GCR33, to distinguish
it from the recombinant form of the protein, pUL33. Immu- GCR33 is 43 kDa and exhibits heterogeneous
nofluorescence was done first as a way of verifying that asparagine-linked glycosylation (N-glycosylation) in
GCR33 is expressed in detectable amounts during infec- HCMV-infected HFFs
tion. Because IgG nonspecifically binds to cytoplasmic
inclusion (CI) structures in HCMV-infected cells via the We next used Western immunoassays to identify the
protein by size. Initial experiments with whole cell lysatesFc portion of the antibody molecule (Furukawa et al.,
1975; Keller et al., 1976), immunofluorescence was done gave high backgrounds of nonspecific immunoreactivity,
so we used membrane preparations as an alternate andusing F(ab)2 fragments (prepared from the anti-33 antise-
rum as described under Materials and Methods) and potentially enriched source of material (see Materials
and Methods). Membrane preparations (20 mg protein)F(ab)2-fluorochrome conjugates of the secondary anti-
bodies. from cells infected with wild-type HCMV or with D33, or
from noninfected cells, were subjected to SDS– PAGEResults of the experiment are summarized in Fig. 3.
The rabbit F(ab)2 anti-33 fragments showed a pattern of followed by Western immunoassay using anti-33 (Fig. 4,
‘‘Membranes’’). Immunoreactive material (see asteriskedfluorescence that localized to the region of the CI in wild-
type HCMV-infected fibroblasts (Fig. 3A). Fluorescence bar, Fig. 4, lane 2), was detected in the preparation from
WT-infected cells, but not in those from D33-infectedin cells infected with the UL33 mutant virus, D33 (Fig.
3B), or in noninfected cells (Fig. 3C) was essentially at (Fig. 4, lane 3) or noninfected (Fig. 4, lane 1) cells. The
broad size range of the immunoreactive material sug-the level of background. This infected-cell-specific fluo-
rescence was not due to nonspecific binding of F(ab)2 gested that it was heterogeneously glycosylated or ag-
gregated, or both. To test for the presence of asparagine-fragments (Fig. 3D); nor was it due to binding of residual
Fc in the rabbit F(ab)2 anti-33 preparation, as evidenced linked oligosaccharides, an amount of sample equal to
that used in lanes 1– 3 was treated with PNGase F (Tare-by detection with an anti-F(ab)2 reagent (Fig. 3E) but not
with an anti-Fc reagent (Fig. 3F). The typical pattern of ntino and Plummer, 1994). This treatment yielded a
strong new band in the WT HCMV-infected cell prepara-CI fluorescence by nonspecific IgG binding in wild-type-
infected cells is shown for comparison (Figs. 3G and 3H). tion (Fig. 4, lane 5) that was absent from both the D33-
infected and noninfected cell preparations (Fig. 4, lanesThe juxtanuclear location and generally spherical shape
of the nonspecific, Fc-binding CIs (Fig. 3J) appeared to 6 and 4, respectively). The 43-kDa size of this band
approximates the computer-predicted molecular weightbe the same as the pattern of specific binding by the
rabbit F(ab)2 anti-33 fragments, shown in the same field of the protein encoded by UL33. The generally increased
(WT; A, D– K, M, and N), HCMV D33 (D33; B and L), or not infected (Mock; C) and processed for indirect immunofluorescence. Primary reagents
used were rabbit F(ab)2 anti-33 (A –C, E, and F), nonspecific rabbit F(ab)2 (D), nonspecific rabbit serum (G and H), nonspecific rabbit Fc (L), a mixture
of nonspecific rabbit Fc and rabbit F(ab)2 anti-33 (J and K), C1 peptide-competed rabbit F(ab)2 anti-33 (M), or UL33 peptide-competed rabbit F(ab)2
anti-33 (N). Secondary reagents used were GFARF-LRSC (A – D, M, and N), GFARFc-FITC (L), or a mix of both (E– K). LRSC fluorescence is shown
in A –E, G, K, M, and N, FITC fluorescence in F, H, J, and L.
AID VY 8199 / 6a21$$$303 10-07-96 21:41:07 vira AP: Virology
118 MARGULIES, BROWNE, AND GIBSON
same extent and (ii) insertion of lacZ into the UL33 ORF
was not deleterious to expression of the adjacent UL32
ORF. We have not further investigated the possible over-
expression of BPP in D33-infected cells (i.e., see Fig. 4;
compare lane 8 with lane 9). These data indicate that
GCR33 is a heterogeneously N-glycosylated protein in
HCMV-infected cells.
HCMV-infected cell-specific GCR33 shows peptide
similarities to rBV-expressed pUL33
Peptide comparisons were used to establish that the
anti-33-reactive, infected-cell-specific protein (Fig. 4,
lanes 2 and 5) is GCR33. Membranes from HCMV-in-
fected HFF cells (treated or not treated with PNGase F)
or rBV-33-infected insect cells were subjected to SDS –
PAGE, followed by in situ protein cleavage with NCS,
separation of the resulting peptides in a second-dimen-
sion gel, and finally Western immunoassay with anti-
33 to identify related peptides, all as explained underFIG. 4. HCMV-infected HFF cells express glycosylated GCR33. HFF
Methods and Materials. All three preparations gave risecells were infected with WT HCMV (WT-Inf.; lanes 2, 5, and 8), HCMV
D33 (D33-Inf.; lanes 3, 6, and 9), or not infected (Mock; lanes 1, 4, and to five comigrating, immunoreactive fragments (Fig. 5,
7). Total cell membranes (Membranes) or whole cells (Cells) were numbered 1– 5). Peptides 4 and 5, although not well dem-
isolated 8 days after infection and incubated with or without PNGase onstrated in this figure (Fig. 5, circles, lanes 1 and 2),
F (//0 PNGase). Membrane protein (20 mg) or whole cell protein (15
were readily detected in longer exposures of this immu-mg) was subjected to SDS –PAGE and analyzed by Western immunoas-
noassay. Correspondence of the peptide patterns forsay; the Membranes blot was probed with rabbit anti-33, and the cells
blot was probed with an antiserum to the basic phosphoprotein (BPP, HCMV-infected-cell GCR33 (with or without PNGase F
protein product of HCMV UL32 ORF) (Greis et al., 1994). The asterisked treatment) and rBV-33-infected-cell pUL33 provides di-
bar represents a molecular weight range of 58 to100 kDa; molecu- rect evidence that the anti-33 reactive HCMV-infected-
lar weight (in kDa) was estimated from molecular weight markers in-
cell protein is the product of the UL33 ORF.cluded during SDS – PAGE that were visualized by staining that portion
of the Immobilon-P with CBB immediately following electrotransfer.
HCMV enveloped virus particles contain glycosylated
GCR33
level of immunoreactivity observed in the PNGase F-
treated HCMV-infected cell preparation (Fig. 4, lane 5) Because GCRs are membrane proteins, enveloped vi-
rus particles were examined for the presence of GCR33likely results from better electrotransfer of the 43-kDa
deglycosylated protein from the gel, compared to the by SDS– PAGE and Western immunoassay. HCMV nonin-
fectious enveloped particles (NIEP or N), virions (VIR orhigher-molecular-weight glycosylated form (Fig. 4, lane
2) (Gibson, 1981a), or to comparatively better retention of V), and dense bodies (DB or D) were prepared from WT
HCMV-infected HFFs (WT) or from D33-infected (D33)the deglycosylated form on the Immobilon-P membrane
(Gibson, 1981a), or both. We attribute the small amount HFFs. A small portion of the pellet from each particle
type was either treated or not treated with peptide N-of large, electrophoretically heterogeneous material that
remained after PNGase F treatment (Fig. 4, lane 5; also glycosidase F (//0 PNGase) and then tested by SDS –
PAGE and Western immunoassay with the anti-33 antise-see Fig. 7, lane 9) to incompletely deglycosylated GCR33
or the tendency of the protein to aggregate, or both. rum (Fig. 6, anti-33). Although two background bands are
present in all samples, detracting from the data, the anti-Whole cell lysates (Fig. 4, ‘‘Cells’’) were also prepared
(15 mg protein per lane) and subjected to SDS – PAGE in 33 antiserum specifically reacted with material in all
three WT HCMV enveloped particles (indicated by cir-the same gel. Western immunoassays were done on
these lysates to establish that the inability to detect a cles, Fig. 6, lanes 5, 9, and 13) but in none of the corre-
sponding D33 particles (Fig. 6, lanes 7, 11, and 15). TheUL33 protein in D33-infected cells was not due to a
generally lower amount of protein in those preparations, diffuse pattern of anti-33 reactivity observed in the WT
HCMV particles (Fig. 6, circles, lanes 5, 9, and 13) wascompared to WT-infected cells. An anti-peptide antise-
rum to the HCMV basic phosphoprotein (BPP, pp150, 149 consistent with that seen in membrane preparations from
WT-infected cells (Fig. 4, lane 2; Fig. 6, lane 3). Also askDa, product of UL32 ORF) (Greis et al., 1994) was used
and showed BPP in both D33- and WT-infected HFFs observed with the membrane preparations (Fig. 6, lane
4), treatment of the WT particles with PNGase F (Fig. 6,(Fig. 4, lanes 8 and 9, respectively), indicating that (i)
the D33 infections had progressed to approximately the lanes 6, 10, and 14) decreased the heterogeneity and
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qualitatively the same in both sets of particle prepara-
tions. Therefore, the absence of anti-33 reactivity with
D33 particles seen in the anti-33 immunoassay (Fig. 6,
lanes 5 –16) was not due to a significantly reduced
amount of D33 virus particles. The ratio of LM to miCP
differed, however, between the WT and D33 particles,
suggesting either that the D33 NIEP and virion prepara-
tions were partially contaminated with dense bodies or
that the absence of GCR33 in some way altered the
protein composition of these D33 particles. The anti-
miCP/anti-LM panel also demonstrates that the dense
body preparations (Fig. 6, lanes 21 and 22) contained
comparatively large amounts of LM but no miCP, as ex-
pected for these particles whose protein composition
is approximately 90% LM and which contain no capsid
structure or capsid protein constituents (Gibson, 1993;
Irmiere and Gibson, 1983). These experiments show that
GCR33 is present in all three types of WT HCMV enve-
loped particles.
GCR33 from HCMV-infected cells and virus particles
is larger than proteins expressed from UL33 or
‘‘spliced UL33’’
FIG. 5. Peptide comparisons show similarities between rBV (pUL33)-
Recent work showed that one of the mRNAs generatedand HCMV-infected cell (GCR33) UL33 proteins. Samples of rBV-33-
infected Sf9 cell proteins (lane 1) and membrane preparations from from UL33 during HCMV infection is a spliced transcript
WT HCMV-infected HFF cells without (lane 2) or with (lane 3) PNGase (Davis-Poynter et al., 1995). This spliced mRNA would
F treatment were subjected to first-dimension SDS –PAGE in a single code for a variant of GCR33 extending 22 amino acids
12% polyacrylamide gel. The region of each sample spanning the size
beyond the amino terminus of the protein encoded byrange of GCR33 and pUL33 was excised from the gel, treated with
the originally defined ORF (Chee et al., 1990b). BecauseNCS to cleave the proteins in situ, and the resulting peptides were
compared by SDS –PAGE in an 18% DATD-crosslinked polyacrylamide the recombinant pUL33, which lacks this amino exten-
gel by electrophoresis perpendicular to the original direction of migra- sion, migrates with a smaller apparent molecular weight
tion (i.e., top to bottom), all as described under Materials and Methods. than the deglycosylated GCR33 from WT HCMV-infected
Peptides in the second-dimension gel were detected by Western immu-
cells during SDS – PAGE, the possibility was tested thatnoassay with the anti-33 antiserum (to the carboxyl end of UL33 pro-
this discrepancy was due to the presence of an amino-tein). Immunoreactive peptides are labeled 1 to 5. Circles indicate
peptides 4 and 5 in lanes 1 and 2. terminal extension on the protein made in WT HCMV-
infected cells. An rBV (rBV-N33) was engineered that
encodes the 22-amino-acid-extended splice variant of
pUL33, called pUL33-XTND, for this purpose.size of the immunoreactive material to approximate the
computer-predicted 43-kDa molecular weight of the pro- The proteins produced by wild-type baculovirus (BV),
rBV-33, rBV-N33, and wild-type HCMV were then com-tein product of UL33.
As part of this experiment, a similar portion of each pared by SDS– PAGE and Western immunoassay using
the anti-33 antiserum (Fig. 7). Membrane preparationsof the samples described above was solubilized more
completely by heating in a boiling water bath prior to from WT HCMV-infected (WT-Inf.) or noninfected (Mock)
cells were treated or not treated with PNGase F (//0SDS– PAGE and was subjected to electrophoresis in the
same gel. A Western immunoassay was done on these PNGase). As expected, pUL33-XTND (produced by rBV-
N33, Fig. 7, lanes 3, 4, and 5, circle) had a larger apparentsamples with a mixture of a rabbit anti-peptide antiserum,
called anti-miCP, against a capsid component, called the molecular weight (i.e., 39 kDa, versus 36 kDa) than
the original pUL33 (Fig. 7, lane 2, circle). The glycosylated‘‘minor capsid protein’’ (miCP, pUL85), and a mouse
monoclonal antibody, called anti-LM, against an abun- and deglycosylated GCR33 (Fig. 7, lane 8, and Fig. 7,
circle, lane 9, respectively) migrated as in Fig. 4, withdant tegument phosphoprotein called the ‘‘lower matrix
protein’’ (LM or pp65, pUL83) (Fig. 6, anti-miCP/anti-LM). apparent molecular weights of ¢58 and 43 kDa, re-
spectively. No similar immunoreactive material was de-The reactivity of these antibodies with D33 particle prep-
arations (Fig. 6, lanes 18, 20, and 22) and WT particle tected in WT baculovirus-infected cells (Fig. 7, BV, lane
1) or noninfected HFFs (Fig. 7, lanes 6 and 7). Thus, thepreparations (Fig. 6, lanes 17, 19, and 21) demonstrated
that the presence of the miCP and LM proteins was amino extension of pUL33-XTND does not fully account
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FIG. 6. HCMV enveloped particles contain glycosylated GCR33. Cell membranes were isolated from noninfected (Mock; lanes 1 and 2) or WT
HCMV-infected (WT; lanes 3 and 4) HFF cells. WT HCMV (WT; lanes 5, 6, 9, 10, 13, 14, 17, 19, and 21) or HCMV D33 (D33; lanes 7, 8, 11, 12, 15,
16, 18, 20, and 22) enveloped extracellular virus particles were used in these experiments; NIEPs (lanes 5 –8, 17, and 18), virions (lanes 9 –12, 19,
and 20), or dense bodies (lanes 13 –16, 21, and 22) were purified from infected cells, treated or not treated with PNGase F (//0 PNGase), and
subjected to SDS – PAGE, followed by Western immunoassay with rabbit anti-33. Circles (lanes 5, 9, and 13) indicate a broad, immunoreactive band
of material in WT NIEPs, virions, and dense bodies. Another set of samples, not treated with PNGase F (lanes 17 – 22), was heated in a boiling
water bath prior to SDS – PAGE in the same gel and then subjected to Western immunoassay with a mixture of anti-miCP (to minor capsid protein)
and anti-LM (to abundant lower matrix tegument protein). The positions of the minor capsid protein (miCP) and lower matrix protein (LM) are
indicated; molecular weight (in kDa) was estimated from molecular weight markers included during SDS – PAGE that were visualized by staining
that portion of the Immobilon-P with CBB immediately following electrotransfer.
for the discrepancy between the observed sizes of pUL33 particles, and (iv) is not essential for replication of HCMV
in cell culture.and deglycosylated GCR33.
We have shown that pUL33 can be expressed from
UL33 ORF is not essential for HCMV growth in cell rBVs in insect cells. Both the wild-type and T7-epitope-
culture tagged forms (Kolodziej and Young, 1991) were excluded
from the nucleus, but a more precise localization wasTo determine whether UL33 is required for HCMV rep-
not achieved due to the small cytoplasmic space in theselication in cell culture, we disrupted the UL33 gene by
spherical Sf9 cells. rBV-encoded and in vitro-translatedinsertional mutagenesis (with the lacZ gene) and intro-
pUL33 (data not shown) comigrated during SDS– PAGE,duced the mutant gene into the HCMV genome by homol-
with an estimated size of 36 kDa (smaller than the com-ogous recombination, as described under Materials and
puter-predicted 43 kDa). The electrophoretic mobility ofMethods. A viable mutant, called D33, was selected on
the rBV product was not affected by treatment withthe basis of its blue-plaque phenotype. The time course
PNGase F (data not shown), indicating that it is not appre-of replication for D33 and WT HCMV were compared
ciably glycosylated in insect cells. This finding was sur-under single-cycle growth conditions (Fig. 8). The results
prising given that GCRs are typically N-glycosylated (Fra-showed that D33 yields approximately the same titer of
ser et al., 1994) and that insect cells are competent forprogeny virus by 4 to 6 days after infection, but D33 titers
the initial steps of this posttranslational modificationwere about 10-fold lower than those of WT HCMV at the
(O’Reilly et al., 1992); the lack of glycosylation may relatefour earlier time points (i.e., 16, 24, 48, and 72 hr after
to interference with cellular N-glycosylation observedinfection).
during the late stages of baculovirus infection (Jarvis and
Summers, 1989). Like other GCRs and highly hydropho-DISCUSSION
bic proteins (Semenza et al., 1990), pUL33 is heat sensi-
The primary findings in this report are that the HCMV tive and aggregated when heated above 607; aggregation
GCR, GCR33 (i) is expressed from recombinant baculovi- was to the extent that essentially none of the protein
rus in insect cells as a 36-kDa, heat-aggregatable pro- was detected in the resolving gel when the sample was
tein (pUL33) that is localized to nonnuclear regions of heated with solubilizing buffer in a boiling water bath.
the cell, (ii) is present in HCMV-infected HFFs as a heter- More importantly, we have identified the UL33 GCR
ogeneously N-glycosylated protein that localizes to the protein, GCR33, in HCMV-infected fibroblasts. Unlike re-
same region as the Fc-binding cytoplasmic inclusion, (iii) combinant pUL33, GCR33 in HCMV-infected cells was
larger and more heterogeneous in size than the com-is also present in three types of HCMV enveloped virus
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et al., 1995) that would give rise to a GCR33 that is 22
amino acids longer at its amino end than rBV pUL33. To
test this last explanation, we cloned and expressed the
ORF that would code for this splice variant from an rBV
and found that, although larger than pUL33, as expected,
it still migrated somewhat faster than deglycosylated
GCR33 during SDS-PAGE (Fig. 7). Thus, the protein de-
tected in HCMV-infected HFFs differs in some way from
the proteins expressed from both the spliced and non-
spliced recombinant forms of UL33 tested here.
Glycosylated GCR33 is also present in virions and two
types of enveloped virus particles called noninfectious
enveloped particles and dense bodies. Because dense
bodies are composed primarily of lower matrix protein
surrounded by the viral envelope (Gibson, 1993; Irmiere
and Gibson, 1983), and GCRs are characteristically mem-
brane proteins, this finding is consistent with GCR33 be-
ing a virus envelope glycoprotein. The presence of
GCR33 in the viral envelope would allow for it being
carried to cells with the virus and being deposited in
the cellular plasma membrane with the rest of the viral
envelope during entry. If introduced into the cell mem-
brane by this mechanism, a functionally competent
FIG. 7. Size comparison of different forms of the protein encoded by HCMV GCR could hypothetically induce the signaling
UL33. Sf9 cells infected with WT baculovirus (BV; lane 1), rBV-33 (lane changes observed in fibroblasts immediately following
2), or rBV-N33 (lanes 3, 4, and 5) were harvested 3 days after infection;
membranes from noninfected (Mock; lanes 6 and 7) or WT HCMV-
infected (WT-Inf.; lanes 8 and 9) HFFs were prepared and treated or
not treated with PNGase F (//0 PNGase). Lane 4 (rBV-N33 1:1) is a
twofold dilution, and lane 3 (rBV-N33 1:3) a fourfold dilution, of the
material in lane 5. All samples were then analyzed by SDS –PAGE and
Western immunoassay with the anti-33 antiserum. Circles indicate the
three forms of the protein encoded by UL33. The asterisked bar indi-
cates a broad molecular weight range of glycosylated GCR33 and
aggregates of GCR33 that are visible near the top of the gel; molecular
weights (in kDa) were estimated from molecular weight markers in-
cluded during SDS – PAGE that were visualized by staining that portion
of the Immobilon-P with CBB immediately following electrotransfer.
puter-predicted 43 kDa, due to asparagine-linked glyco-
sylation. Treatment with PNGase F reduced the size to
43 kDa, close to the predicted size, but larger than the
36-kDa size of rBV pUL33. This mobility difference
could be due to several causes. First, infected-cell
GCR33 may bear additional modifications (Fraser et al.,
1994) that are absent from the rBV product and possibly
produced by infected-cell-specific enzymes. If such dif-
ferences are present, they are not likely to be at the
carboxyl end of GCR33 because peptide comparisons
revealed no mobility differences among the five carboxy-
FIG. 8. The UL33 ORF is dispensable for growth in cell culture.
coterminal peptides detected (Fig. 5). Second, the recom- Monolayers of MRC5 cells were infected with WT HCMV or D33 viruses
binant protein may have an increased electrophoretic at a multiplicity of infection of 5 and washed three times with medium
containing 10% FCS after adsorption. Supernatant virus was collectedmobility due to misfolding (e.g., intramolecular hydropho-
at 16, 24, 48, 72, 96, and 144 hr after infection and was assayed bybic interactions of transmembrane domains) or incom-
plaquing on a fresh monolayer of MRC5 cells (Browne et al., 1992;plete denaturation. A third explanation is that the in-
Kaye et al., 1992). Duplicate assays were performed from duplicate
fected-cell protein is actually larger. This possibility is infections for each time point. Shown here is a one-step growth curve;
attractive in view of the recent finding that the UL33 standard errors were not greater than 6% between the two sets of
measurements that were averaged.mRNA exists in an additional spliced form (Davis-Poynter
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TABLE 1
FASTA Comparison of GCR33, Other Viral GCRs, and Representative Chemokine Receptors
Class Species ORF/Receptor a Closest relative (class)b Scorec
b-Herpes HCMV GCR33 RANTES (b) 313
b-Herpes HCMV GCR33-XTND RANTES (b) 313
b-Herpes HCMV US27 RANTES (b) 420
b-Herpes HCMV US28 RANTES (b) 562
b-Herpes HCMV UL78 f-MLP (N/A) 157
b-Herpes HHV-6 U12 RANTES (b) 245
b-Herpes HHV-6 U51 m-opioid (N/A) 182
b-Herpes HHV-7 ORF 17 RANTES (b) 224
b-Herpes HHV-7 ORF 57 IL-8RB (a) 185
(g-Herpes) (Human) EBI-1 IL-8RB (a) 681
(g-Herpes) (Human) EBI-2 RANTES (b) 533
g-Herpes EHV-2 E1 RANTES (b) 1087
g-Herpes EHV-2 74 RANTES (b) 312
g-Herpes HVS ECRF3 IL-8RB (a) 428
Poxvirus Swinepox K2R RANTES (b) 573
Poxvirus Capripox Q2/3L RANTES (b) 705
a The ORF or the receptor is given by locus number or common receptor name (Attwood and Findlay, 1994; Birkenbach et al., 1993; Chee et al.,
1990a; Davis-Poynter et al., 1995; Gompels et al., 1995; Horuk, 1994; Massung et al., 1993; Murphy, 1994a; Nicholas et al., 1992; Telford et al., 1995).
The EBI-1 and -2 ORFs are human genes induced by EBV, HHV-6, and HHV-7 infection.
b The most closely related human GCR of known function is listed. The chemokine receptor class for each relative is also shown in parentheses.
HCMV UL78 and HHV-6 U51 are marked N/A because the closest relatives are not chemokine receptors.
c Optimized FASTA score of closest relative. Scores above 100 are considered significant.
HCMV infection (Albrecht et al., 1991), as suggested pre- its spliced mRNA show homology with known b-chemo-
kine receptors (see FASTA scores, Table 1) (Kolakowski,viously (Welch et al., 1991).
As shown in Fig. 3, GCR33 localizes to the region of 1994). The longer amino terminus of the protein encoded
by the spliced mRNA, GCR33-XTND (Davis-Poynter et al.,the cytoplasmic inclusions (CIs). This result is intriguing,
considering that GCRs normally appear at the cell sur- 1995), would contain four more asparagine-linked glyco-
sylation sites than GCR33, one more cysteine, and wouldface (Zastawny et al., 1994). Several explanations could
account for the predominant CI localization of GCR33. have a slightly acidic charge, all characteristics of the
amino termini of chemokine receptors (Ahuja and Mur-First, its distribution may not be accurately reflected by
immunofluorescence. For example, plasma membrane- phy, 1993; Horuk, 1994; Murphy, 1994a,b). Also, se-
quences in the second transmembrane domain and thirdlocalized GCR33 may be partially extracted or denatured
during fixation and permeabilization; it may not be well transmembrane domain extending into the second intra-
cellular loop are 55% homologous (18% identical) topresented for the antibodies to react; or it may be as
abundant as it is in CIs, but less regionally concentrated, amino acid stretches found in those regions of chemo-
kine receptors (Charo et al., 1994). Thus, either theand hence less readily detected. A second explanation
is that GCR33 has an intracellular function, perhaps in spliced or nonspliced mRNA from UL33 may encode a
chemokine receptor (Table 1).addition to its surface role. HSV-1 glycoprotein gK offers
a possible parallel in that it appears to localize predomi- Other viral GCRs also show similarities to chemokine
receptors. Both HCMV US28 and herpesvirus saimirinantly intracellularly by immunofluorescence and yet is
involved in syncytia formation, suggesting a surface loca- ECRF3 (Nicholas et al., 1992) encode functional chemo-
kine receptors (Ahuja and Murphy, 1993; Gao and Mur-tion (Hutchinson et al., 1995). Third, if GCR33 is a func-
tional receptor, it may be internally sequestered as a phy, 1994; Kuhn et al., 1995; Neote et al., 1993; Vieira et
al., 1995). Human herpesviruses 6 and 7 (HHV-6 and -7),means of downregulating its activity (Fraser et al., 1994;
Saffitz and Liggett, 1992; Zastawny et al., 1994); such a other members of the human b-herpesvirus group like
HCMV, encode GCR homologues related to chemokinesequestration could hypothetically involve translocation
of GCR33 from the cell surface to the CIs. A fourth expla- receptors (Gompels et al., 1995) (Table 1), and the rodent
b herpesviruses murine CMV and rat CMV encode posi-nation, based on the presence of GCR33 in enveloped
virus particles, is that the protein may be targeted to this tionally conserved homologues of UL33 (Beisser et al.,
1995; Davis-Poynter et al., 1995). In addition, homologuesregion to be incorporated into maturing virions.
A ligand for GCR33 has not yet been identified, but the of chemokine receptors are encoded by the Epstein –
Barr virus-induced cellular GCR mRNAs (Birkenbach etprotein products from both its nonspliced and especially
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G protein-coupled peptide receptors. J. Virol. 67, 2209–2220.
the recently described human g herpesvirus, Kaposi’s Browne, H., Churcher, M., and Minson, T. (1992). Construction and
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Recently, swinepox and capripox viruses have also been coding a G-protein-coupled chemokine receptor homologue. Virology
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91, 2752– 2756.
virus replication in cell culture (Jones et al., 1995), it will Chee, M. S., Bankier, A. T., Beck, S., Bohni, R., Brown, C. M., Cerny, R.,
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